Company / Free Cash Flow per Share
Niagen Bioscience, Inc. Free Cash Flow per Share History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$384.51
FY2019
5-year range
-
FY2016-FY2019
Trend
-191598.8%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -191599% YoY in FY2019, a notable deviation from the 3-year average annual change of -63901%.
Based on SEC 10-K filings.
-384.51 in FY2019.
Declined from $-0.29 to $-384.51 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, free cash flow per share decreased 191598.8% year-over-year.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -$384.51 | -191598.8% |
| FY2018 | -$0.20 | +31.4% |
| FY2017 | -$0.29 | -136.9% |
| FY2016 | -$0.12 | -392.6% |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026